News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|March 22, 2017

About the Colonoscopy

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
Stage 3 colon cancer patients who tested MRD+ with Signatera after surgery saw a meaningful survival benefit from Celebrex and chemo: © stock.adobe.com.

This Test Helped Identify Treatment in Colorectal Cancer Surgery

ByRyan Scott
December 19th 2025
The FDA granted fast track status to muzastotug plus Keytruda for adults with microsatellite stable metastatic colorectal cancer without liver metastases: © stock.adobe.com.

FDA Grants Fast Track Status to Muzastotug for Some Colorectal Cancers

BySpencer Feldman
December 16th 2025
Image of two people.

Experts Highlight Notable Advances in Colorectal Cancer at 2025 ESMO

ByDr. Joshua K. Sabari
November 13th 2025
Image of hands.

I’m Still Here: My Fight Against Colorectal Cancer

ByChrista Messmer
October 28th 2025
Between paying for treatment, managing a reduced income, and understanding insurance, the financial side of cancer can feel overwhelming.

Financial Planning Support for People and Families Impacted by Cancer

ByTriage Cancer®
October 16th 2025
Advertisement
Advertisement

Trending on CURE

1

Top 5 Breast Cancer Updates From the 2025 San Antonio Breast Cancer Symposium

2

Top 10 Cancer Care Updates of 2025: What Patients Should Know

3

Finding Cancer Support in Different Places For Different Diagnoses

4

FDA Grants Breakthrough Status to Enhertu for Some HER2+ Early Breast Cancers

5

Clinical Trials: Tomorrow's Treatment Today in Metastatic Breast Cancer

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.